Litigation Details for Sanofi-Aventis U.S. LLC v. Aurobindo Pharma Limited (D. Del. 2022)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Aurobindo Pharma Limited (D. Del. 2022)
Docket | ⤷ Subscribe | Date Filed | 2022-01-31 |
Court | District Court, D. Delaware | Date Terminated | 2022-04-29 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,583,110; 8,927,592 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Aurobindo Pharma Limited
Details for Sanofi-Aventis U.S. LLC v. Aurobindo Pharma Limited (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-01-31 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2 ; 10,716,777 B2…2022 29 April 2022 1:22-cv-00141 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-04-29 | 9 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2; 10,716,777 B2;…2022 29 April 2022 1:22-cv-00141 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |